Search Results for "Bacterial Conjunctivitis"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Bacterial Conjunctivitis. Results 11 to 20 of 21 total matches.
Azelaic Acid (Finacea) for Rosacea
The Medical Letter on Drugs and Therapeutics • Sep 15, 2003 (Issue 1165)
. Ocular involvement such as blepharitis or conjunctivitis is common; keratitis and corneal scarring occur ...
Azelaic acid 15% gel (Finacea Berlex) is now available in the US for treatment of mild to moderate rosacea. A 20% cream formulation of the drug (Azelex Allergan; Medical Letter 1996; 38:52) has been marketed here since 1996 for treatment of acne. The effectiveness of Finacea compared to its own vehicle and to metronidazole gel is discussed. Information on the drug's mechanism of action, adverse effects, dosage and cost are also included.
Drugs for Rosacea
The Medical Letter on Drugs and Therapeutics • Feb 05, 2024 (Issue 1695)
(a bulbous nose), particularly in men.
Blepharitis and conjunctivitis are common. Keratitis
and corneal ...
Rosacea is a common, chronic inflammatory facial
eruption of unknown cause. It is more prevalent
in women than in men, and disease onset typically
occurs after age 30. Rosacea is characterized
by erythema, telangiectasia, and flushing, and
sometimes by recurrent, progressive crops of
acneiform papules and pustules, usually on the
central part of the face. Some patients develop
granulomas and tissue hypertrophy, which may lead
to rhinophyma (a bulbous nose), particularly in men.
Blepharitis and conjunctivitis are common. Keratitis
and corneal scarring occur rarely.
Med Lett Drugs Ther. 2024 Feb 5;66(1695):21-2 doi:10.58347/tml.2024.1695b | Show Introduction Hide Introduction
Drugs and Vaccines Against Biological Weapons
The Medical Letter on Drugs and Therapeutics • Oct 15, 2001 (Issue 1115)
, anthrax vaccine is given at 0, 2
and 4 weeks, accompanied throughout by an appropriate antibiotic ...
Concerns have arisen anew about possible use of biological weapons. The pathogens considered most likely to be used for this purpose are discussed in this article. A good source for additional information is www.usamriid.army.mil/education/bluebook.html.
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics • Jun 27, 2022 (Issue 1653)
, partners should be
examined and tested for STIs, but in most cases
partner treatment of bacterial STIs ...
This article includes recommendations for management
of most sexually transmitted infections (STIs)
other than HIV and viral hepatitis. Some of the
indications and dosages recommended here have
not been approved by the FDA (see Table 1).
Dermal Fillers
The Medical Letter on Drugs and Therapeutics • May 07, 2007 (Issue 1260)
of wrinkles and folds.
1
These fillers are
often used in conjunction with botulinum toxin type A
(Botox ...
Several injectable products are available for soft tissue augmentation of wrinkles and folds. These fillers are often used in conjunction with botulinum toxin type A (Botox) injections.
Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis
The Medical Letter on Drugs and Therapeutics • Apr 24, 2017 (Issue 1519)
patients who received every-otherweek
dupilumab monotherapy in the SOLO studies,
conjunctivitis occurred ...
The FDA has approved dupilumab (Dupixent – Sanofi/Regeneron), a subcutaneously-injected fully human
monoclonal antibody, for treatment of adults with
moderate to severe atopic dermatitis (eczema) that
has not responded to topical therapies. It can be used
with or without topical corticosteroids.
Prevention and Treatment of Injury from Chemical Warfare Agents
The Medical Letter on Drugs and Therapeutics • Jan 07, 2002 (Issue 1121)
to liquid or vapor mustard range from ocular irritation and conjunctivitis to corneal burns and blindness ...
The recent terrorist attacks on the US have led to many questions about the clinical effects, prevention and treatment of injury caused by chemical warfare agents.
Comparison Table: Some Drugs for Plaque Psoriasis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 30, 2024 (Issue 1712)
, then 40 mg q2
weeks (40 mg/week
may be needed in
some patients)
▶ Serious bacterial infections ...
View the Comparison Table: Some Drugs for Plaque Psoriasis
Med Lett Drugs Ther. 2024 Sep 30;66(1712):e160-6 doi:10.58347/tml.2024.1712b | Show Introduction Hide Introduction
Drugs for Asthma
The Medical Letter on Drugs and Therapeutics • Nov 25, 2024 (Issue 1716)
Chronic
azithromycin use can lead to antibiotic resistance,
hearing loss, and QT-interval prolongation ...
The goal of asthma treatment is to control symptoms,
prevent exacerbations, and maintain normal lung
function. Management of acute exacerbations in the
emergency department is not discussed here.
Med Lett Drugs Ther. 2024 Nov 25;66(1716):185-92 doi:10.58347/tml.2024.1716a | Show Introduction Hide Introduction
Drugs for Plaque Psoriasis
The Medical Letter on Drugs and Therapeutics • Sep 30, 2024 (Issue 1712)
bacterial infections,
histoplasmosis, and reactivation of hepatitis B virus
and tuberculosis (TB ...
Mild to moderate plaque psoriasis can be treated
with topical drugs and phototherapy. Patients
with moderate to severe disease generally require
systemic therapy. Guidelines for the treatment of
psoriasis with topical therapy, phototherapy, and
systemic drugs have recently been published.
Med Lett Drugs Ther. 2024 Sep 30;66(1712):153-60 doi:10.58347/tml.2024.1712a | Show Introduction Hide Introduction